TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34535979

Group type: EXPERIMENTAL
Intervention: Telemonitoring intervention with four daily short text messages for 30 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telemonitoring intervention
Number of subjects: 0
Study: 34984851

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cholecalciferol
Number of subjects: 20
Study: 34665055

Group type: EXPERIMENTAL
Intervention: Aggressive heating with three different heaters (compressed-air blower heater, intravenous fluid heating, heating bed)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Standard compressed-air blower heater
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Aggressive heating
Number of subjects: 39
Study: 34632798

Group type: EXPERIMENTAL
Intervention: Saturated fat ingestion
Number of subjects: 40
Study: 35674747

Group type: EXPERIMENTAL
Intervention: Low-dose triple combination therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 34127756

Group type: EXPERIMENTAL
Intervention: Updated Swedish reference ranges for estimated fetal weight (EFW) using Hadlock's 3rd formula from gestational week 12 to 42.
Number of subjects: 583
Study: 34187547

Group type: EXPERIMENTAL
Intervention: Conversation-based decision aid (Option Grid) containing cost information about slow-growing prostate cancer management options, combined with urologic surgeon training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 0
Study: 35977772

Group type: EXPERIMENTAL
Intervention: Positive psychology intervention (PPI) workshop covering four techniques: gratitude visits/letters, three good things, you at your best, using signature strengths; duration of 1.5 hours with a booster intervention at 1 week.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 120
Study: 33097936

Group type: EXPERIMENTAL
Intervention: DHA supplementation (∼4 g/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ALA supplementation (∼4 g/d)
Number of subjects: 0
Study: 32357322

Group type: EXPERIMENTAL
Intervention: Dopamine
Number of subjects: 2634

Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 2634

Group type: COMPARATOR
Intervention: Phenylephrine
Number of subjects: 2634
Study: 36115558

Group type: EXPERIMENTAL
Intervention: PTCS-guided PDT
Number of subjects: 39

Group type: COMPARATOR
Intervention: PTCD
Number of subjects: 39
Study: 35636772

Group type: EXPERIMENTAL
Intervention: Therapist supported online remote behavioural intervention for tics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 33504211

Group type: EXPERIMENTAL
Intervention: PPD
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Candida antigen
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: MMR vaccine
Number of subjects: 150
Study: 32029008

Group type: EXPERIMENTAL
Intervention: Thunder-fire moxibustion
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ibuprofen sustained-release capsules
Number of subjects: 100
Study: 35576498

Group type: EXPERIMENTAL
Intervention: Rapid Syllable Transition Treatment (ReST)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Intensive AAC intervention
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Blended intervention (combination of ReST and AAC)
Number of subjects: 4
Study: 33625063

Group type: EXPERIMENTAL
Intervention: VIBESR (deep learning-based superresolution reconstruction)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: VIBESR
Number of subjects: 46

Group type: COMPARATOR
Intervention: VIBESD (standard VIBE images)
Number of subjects: 46
Study: 32651146

Group type: EXPERIMENTAL
Intervention: Reduced‐osmolarity ORS and propranolol (n = 34)
Number of subjects: 70

Group type: COMPARATOR
Intervention: No medication (Control group, n = 36)
Number of subjects: 70
Study: 36316831

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral reflective training programme (CBRT-P)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 163
Study: 32349074

Group type: EXPERIMENTAL
Intervention: Calibrated esophageal pressure measurements during pneumoperitoneum-Trendelenburg and PEEP administration
Number of subjects: 30

Group type: COMPARATOR
Intervention: Uncalibrated esophageal pressure measurements
Number of subjects: 30
Study: 33727997

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided pudendal nerve block combined with deep sedation using propofol (Group PNB)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Spinal anesthesia (Group SA)
Number of subjects: 120
Study: 32932396

Group type: EXPERIMENTAL
Intervention: Addipak (n = 12)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: PuriLens Plus (n = 15)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Buffered and nonbuffered saline solutions
Number of subjects: 27
Study: 36156472

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 5000 IU/day for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34339851

Group type: EXPERIMENTAL
Intervention: LBBAP-optimized CRT (LOT-CRT)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Biventricular pacing (BiV-CRT)
Number of subjects: 112

Group type: COMPARATOR
Intervention: LBBAP
Number of subjects: 112
Study: 35731881

Group type: EXPERIMENTAL
Intervention: Conversations about their perfect day
Number of subjects: 2

Group type: COMPARATOR
Intervention: Conversations focusing on disagreement (e.g., why each supports their own party)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Conversations (both studies)
Number of subjects: 2
Study: 32077140

Group type: EXPERIMENTAL
Intervention: Meclizine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 616586506

Group type: EXPERIMENTAL
Intervention: Normative message indicating participant is in the lowest 20th percentile of intake
Number of subjects: 167

Group type: COMPARATOR
Intervention: Control group (no FV message)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Recommendation group (4-5 cups per day)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Normative group (80% of students ate more)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Normative group (80% of students ate less)
Number of subjects: 167
Study: 615918851

Group type: EXPERIMENTAL
Intervention: Dexamethasone intravitreal implant (Ozurdex)
Number of subjects: 40
Study: 35319976

Group type: EXPERIMENTAL
Intervention: Empathic-mindset intervention (45-70 min online exercise)
Number of subjects: 5822

Group type: COMPARATOR
Intervention: Active placebo control
Number of subjects: 5822
Study: 33577373

Group type: EXPERIMENTAL
Intervention: Ziv-aflibercept
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control (existing anti-VEGF regimen)
Number of subjects: 56
Study: 32845114

Group type: EXPERIMENTAL
Intervention: Roflumilast cream 0.5%
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Roflumilast cream 0.15%
Number of subjects: 89

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 89
Study: 34645147

Group type: COMPARATOR
Intervention: Intensive insulin therapy alone
Number of subjects: 32

Group type: COMPARATOR
Intervention: Intensive insulin therapy + glutamine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional insulin therapy + glutamine
Number of subjects: 32
Study: 35130547

Group type: EXPERIMENTAL
Intervention: IQP-LU-104 high dose (104HD)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: IQP-LU-104 low dose (104LD)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 34029168

Group type: EXPERIMENTAL
Intervention: Highly interactive consent form
Number of subjects: 576

Group type: COMPARATOR
Intervention: Other consent form variations
Number of subjects: 576
Study: 32732353

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg every 6 months (Q6M)
Number of subjects: 909

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg every 3 months (Q3M)
Number of subjects: 909

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 909

Group type: EXPERIMENTAL
Intervention: Denosumab (all dose groups)
Number of subjects: 909
Study: 35731737

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (0, 0.5, 1, 2.5, 5, and 10 mM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cadmium (150 μM)
Number of subjects: 0
Study: 33789616

Group type: EXPERIMENTAL
Intervention: rHSA/G‐CSF 1500 μg
Number of subjects: 320

Group type: COMPARATOR
Intervention: rhG‐CSF 5 μg/kg
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: rHSA/G‐CSF 2400 μg
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: rHSA/G‐CSF 1800 μg to 2400 μg
Number of subjects: 320
Study: 32624429

Group type: EXPERIMENTAL
Intervention: Formal education (instructional video on proper TEA technique)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Traditional bedside training by attending physicians
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both groups (formal education and traditional training)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: More experienced residents (having placed more epidural catheters)
Number of subjects: 76
Study: 34535402

Group type: EXPERIMENTAL
Intervention: LIFT (lower-body resistance exercise priming; trap bar deadlifts, 6 × 4 repetitions up to 85% of one repetition maximum)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: RUN (cricket-specific running priming; 6 × 35.36 m sprints including a 180° change of direction)
Number of subjects: 16

Group type: COMPARATOR
Intervention: CON (passive rest)
Number of subjects: 16
Study: 32165399

Group type: EXPERIMENTAL
Intervention: 40 mg of MS-Contin (morphine)
Number of subjects: 21
Study: 34242911

Group type: EXPERIMENTAL
Intervention: WFM (Tiger Tech Warfighter Monitor)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Chest ECG (2-lead)
Number of subjects: 26
Study: 35385827

Group type: EXPERIMENTAL
Intervention: Vi polysaccharide (ViPS) vaccine
Number of subjects: 62756

Group type: EXPERIMENTAL
Intervention: Better household WASH
Number of subjects: 62756

Group type: COMPARATOR
Intervention: Better household WASH in Hep A clusters
Number of subjects: 62756

Group type: COMPARATOR
Intervention: Better household WASH in ViPS clusters
Number of subjects: 62756

Group type: COMPARATOR
Intervention: Better household WASH in the population during the 2 years preceding the trial
Number of subjects: 62756
Study: 33317658

Group type: EXPERIMENTAL
Intervention: Coloured versions of the Health Star Rating label
Number of subjects: 7545

Group type: EXPERIMENTAL
Intervention: Health Star Rating label with just a summary indicator
Number of subjects: 7545

Group type: COMPARATOR
Intervention: Monochrome labels providing nutrient-specific information
Number of subjects: 7545
Study: 36083811

Group type: EXPERIMENTAL
Intervention: Complex of functional spatially oriented rehabilitation (including exercises with instructor, mechanotherapeutic technique with cyclic simulators, massage of paretic limbs)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Basic standard of rehabilitation alone (control group)
Number of subjects: 44
Study: 34549356

Group type: EXPERIMENTAL
Intervention: Succinylated gelatin (4%) (GEL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Compound sodium lactate (CSL)
Number of subjects: 40
Study: 35812820

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG; ATCC 53103)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35077606

Group type: EXPERIMENTAL
Intervention: MZ-004 900 μg
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: MZ-004 1200 μg
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: MZ-004 (both doses)
Number of subjects: 76
Study: 33278280

Group type: EXPERIMENTAL
Intervention: Early pregnancy loss treatment
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Black participants
Number of subjects: 275

Group type: COMPARATOR
Intervention: Non-Black participants
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Adjusted odds for Black participants
Number of subjects: 275
Study: 32482490

Group type: EXPERIMENTAL
Intervention: CVT-301 (levodopa inhalation powder) 84 mg (+25 mg of oral carbidopa)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Oral carbidopa/levodopa (25/100 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: CVT-301
Number of subjects: 23
Study: 33836658

Group type: EXPERIMENTAL
Intervention: Lidocaine coinfusion (1 mg/kg bolus followed by 2 mg/kg/h infusion)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Normal saline (equivalent volume bolus and infusion)
Number of subjects: 106
Study: 33393600

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:200,000 epinephrine
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Twin mix (2% lidocaine with 1:200,000 epinephrine and 1 mL of 4 mg dexamethasone)
Number of subjects: 78
Study: 33370786

Group type: EXPERIMENTAL
Intervention: Wii-based program (n = 6)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (n = 6)
Number of subjects: 12
Study: 32546431

Group type: EXPERIMENTAL
Intervention: Tezacaftor/ivacaftor
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 36057658

Group type: EXPERIMENTAL
Intervention: Combined complex decongestive therapy (CDT) with therapeutic ultrasound
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Combined complex decongestive therapy (CDT) with faradic current
Number of subjects: 39

Group type: COMPARATOR
Intervention: Complex decongestive therapy (CDT) alone (Control)
Number of subjects: 39
Study: 34078453

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention (6-week online training)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (6-week online training)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study: 34289784

Group type: EXPERIMENTAL
Intervention: Calcipotriol 0.005% cream
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tacrolimus 0.03% ointment
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Topical corticosteroid; Clobetasone butyrate 0.05% cream
Number of subjects: 80

Group type: COMPARATOR
Intervention: Petrolatum (Placebo)
Number of subjects: 80
Study: 34561667

Group type: EXPERIMENTAL
Intervention: Social stories
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard leaflets
Number of subjects: 16
Study: 34385669

Group type: EXPERIMENTAL
Intervention: Personalized melanoma genomic risk information (saliva sample for genetic testing, personalized melanoma risk booklet, telephone-based genetic counseling, educational booklet)
Number of subjects: 1025

Group type: COMPARATOR
Intervention: Educational booklet (control group)
Number of subjects: 1025

Group type: EXPERIMENTAL
Intervention: Personalized melanoma genomic risk information
Number of subjects: 1025
Study: 36412685

Group type: EXPERIMENTAL
Intervention: [18F]fluciclovine PET/CT
Number of subjects: 138

Group type: COMPARATOR
Intervention: [18F]fluorocholine PET/CT
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: [18F]fluciclovine PET/CT (per-region analysis)
Number of subjects: 138

Group type: COMPARATOR
Intervention: [18F]fluorocholine PET/CT (per-region analysis)
Number of subjects: 138
Study: 34244055

Group type: EXPERIMENTAL
Intervention: Rifampicin resistance isolates with mutations in rpoB gene
Number of subjects: 702
Study: 36176149

Group type: EXPERIMENTAL
Intervention: Robot-Assisted Therapy protocol with gesture training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Expanded interaction possibilities to total body movements
Number of subjects: 0
Study: 34366306

Group type: EXPERIMENTAL
Intervention: SMART: SmPh app-driven break reminders (visual exercise prompts) plus pedometer-based step intervention
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: TRADE: worksite PA education with a manual plus American College of Sports Medicine guided PA prescription
Number of subjects: 159

Group type: COMPARATOR
Intervention: CONTROL: usual work group
Number of subjects: 159
Study: 35580661

Group type: EXPERIMENTAL
Intervention: Endoscopic step-up approach
Number of subjects: 83

Group type: COMPARATOR
Intervention: Surgical step-up approach
Number of subjects: 83
Study: 34570799

Group type: EXPERIMENTAL
Intervention: Self-collected specimens
Number of subjects: 2458

Group type: EXPERIMENTAL
Intervention: Self-collected pharyngeal specimens
Number of subjects: 2458

Group type: EXPERIMENTAL
Intervention: Self-collected rectal specimens
Number of subjects: 2458
Study: 33361868

Group type: EXPERIMENTAL
Intervention: Artificial Intelligence method for estimating fetal weights
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Another AI method created with all of the JSUM data
Number of subjects: 0

Group type: COMPARATOR
Intervention: Published formulae for estimating fetal weights
Number of subjects: 0
Study: 35477086

Group type: EXPERIMENTAL
Intervention: Stress Management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 32652243

Group type: EXPERIMENTAL
Intervention: 5 tablets of 5‐mg oxycodone
Number of subjects: 120

Group type: COMPARATOR
Intervention: 10 tablets of 5‐mg oxycodone
Number of subjects: 120
Study: 36028870

Group type: EXPERIMENTAL
Intervention: propofol‐remifentanil‐rocuronium‐sugammadex (group S)
Number of subjects: 84

Group type: COMPARATOR
Intervention: cisatricurium and neostigmine (group C)
Number of subjects: 84
Study: 32613345

Group type: EXPERIMENTAL
Intervention: Robotic partial mesorectal excision (R‐PME)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Laparoscopic partial mesorectal excision (L‐PME)
Number of subjects: 131
Study: 34003370

Group type: EXPERIMENTAL
Intervention: Routine clinical rehabilitation program + normoxic endurance training
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Routine clinical rehabilitation program + hypoxic endurance training
Number of subjects: 39

Group type: COMPARATOR
Intervention: Routine clinical rehabilitation program
Number of subjects: 39
Study: 32488245

Group type: EXPERIMENTAL
Intervention: Khorasan wheat products
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control products made from organic semi‐whole‐grain modern wheat
Number of subjects: 20
Study: 35969632

Group type: EXPERIMENTAL
Intervention: Placebo ELLIPTA dry-powder inhaler (DPI)
Number of subjects: 1232
Study: 33463746

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maximum likelihood estimation and ordinary-least-square-based two-stage estimation methods
Number of subjects: 0
Study: 33119010

Group type: EXPERIMENTAL
Intervention: Probiotic yogurt
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ordinary yogurt (Control)
Number of subjects: 90
Study: 32847466

Group type: EXPERIMENTAL
Intervention: Urban online group (telerehabilitation)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Regional online group (telerehabilitation)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Urban in-person group (control)
Number of subjects: 52
Study: 33483125

Group type: EXPERIMENTAL
Intervention: Emotions 101 course (n = 120)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Wait-list condition (n = 123)
Number of subjects: 243
Study: 34134864

Group type: EXPERIMENTAL
Intervention: Video education
Number of subjects: 67

Group type: COMPARATOR
Intervention: Written pamphlet education
Number of subjects: 67
Study: 33229690

Group type: EXPERIMENTAL
Intervention: Manual marking (Group 1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Digital marking (Group 2)
Number of subjects: 50
Study: 35964449

Group type: EXPERIMENTAL
Intervention: Psilocybin (Schedule I)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Methamphetamine (Schedule II)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Ketamine (Schedule III)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Alprazolam (Schedule IV)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Alcohol
Number of subjects: 181
Study: 34606313

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intermittently scanned continuous glucose monitoring
Number of subjects: 0
Study: 35275166

Group type: EXPERIMENTAL
Intervention: Multicomponent safety intervention including education on fall prevention, home medication review, home safety assessment, and occupational therapy home visits.
Number of subjects: 1396

Group type: COMPARATOR
Intervention: Control group from the Systematic Assessment and Targeted Improvement of Services Following Yearly Surgical Outcomes Surveys.
Number of subjects: 1396

Group type: EXPERIMENTAL
Intervention: Multicomponent safety intervention
Number of subjects: 1396
Study: 34460132

Group type: EXPERIMENTAL
Intervention: Melatonin plus standard care
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 96
Study: 34808519

Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA for 20 min)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 24
Study: 36319968

Group type: EXPERIMENTAL
Intervention: CNN model with clinical features
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Radiomics Rad-score
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Deep learning signatures
Number of subjects: 720
Study: 33891508

Group type: EXPERIMENTAL
Intervention: Nintendo Ring Fit Adventure (RFA) exergame, performed once a week for 40 minutes for 8 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Oral treatment for 8 weeks
Number of subjects: 20
Study: 35164484

Group type: EXPERIMENTAL
Intervention: Miller size 0 blade
Number of subjects: 40

Group type: COMPARATOR
Intervention: Macintosh size 0 blade
Number of subjects: 40
Study: 35536547

Group type: EXPERIMENTAL
Intervention: Autologous dendritic cell vaccine (DCVAC)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard-of-care chemotherapy
Number of subjects: 82
Study: 33215434

Group type: EXPERIMENTAL
Intervention: Central European diet (CED)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Mediterranean diet (MED)
Number of subjects: 144
Study: 32672505

Group type: EXPERIMENTAL
Intervention: Interactive safety decision aid (myPlan)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Healthcare provider for contraception
Number of subjects: 354
Study: 32201619

Group type: EXPERIMENTAL
Intervention: Early BCG vaccination
Number of subjects: 6500

Group type: EXPERIMENTAL
Intervention: Early BCG vaccination (administered in November to January)
Number of subjects: 6500

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 6500